Clinical Trials Browser

Phase 4 × Zoledronic Acid × Clear all

Breast Neoplasms

Breast Neoplasms

Multiple Myeloma

Breast Neoplasms

Multiple Myeloma, Osteolysis, Osteonecrosis

Multiple Myeloma

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

Multiple Myeloma

Lung Metastases

Carcinoma, Non-Small-Cell Lung

Bone Diseases, Metabolic, Osteoporosis, Prostatic Neoplasms

Breast Neoplasms, Pain

Neoplasm Metastasis, Neoplasms, Pain

Prostatic Neoplasms

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

Prostatic Neoplasms

Prostatic Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Pain, Prostatic Neoplasms

Breast Neoplasms, Prostatic Neoplasms

Carcinoma, Renal Cell, Neoplasm Metastasis

Prostatic Neoplasms

Prostatic Neoplasms

Multiple Myeloma

Breast Neoplasms

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms

Multiple Myeloma

Prostatic Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

Clinical Trials

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

REaCT-ZOL

IFM-01-04

Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid

Magnolia

Z-MARK

REaCT-BTA

AZABACHE

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer

The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

ER11-03

Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer

Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases

Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma.

A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss

MACS1295

Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis

A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

A Multiple Myeloma Trial in Patients With Bone Metastases

Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis

Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients

Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis

Non-small Cell Lung Cancer Registry